A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

NCT00481702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Intra-abdominal Infection

Interventions

DRUG: Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks
DRUG: MK0826, /Duration of Treatment : 8 Weeks
DRUG: Comparator: metronidazole / Duration of Treatment: 8 Weeks

Sponsor

Merck Sharp & Dohme LLC